IFP Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$53.3K Buy
183
+158
+632% +$52.3K ﹤0.01% 2358
2026
Q2
$8.37K Buy
25
+19
+317% +$6.02K ﹤0.01% 3509
2026
Q1
$1.93K Hold
6
– – ﹤0.01% 3974
2025
Q4
$1.77K Buy
6
+3
+100% +$559 ﹤0.01% 3884
2025
Q3
$159 Buy
+3
New +$145 ﹤0.01% 4444
2025
Q2
– Sell
-1
Closed -$38 – 3923
2025
Q1
$38 Hold
1
– – ﹤0.01% 4074
2024
Q4
$77 Buy
+1
New +$72 ﹤0.01% 4126
2023
Q4
– Sell
-33
Closed -$855 – 3266
2023
Q3
$855 Buy
+33
New +$624 ﹤0.01% 3032

Other funds holding PRAX

IFP Advisors's PRAX Position: Q3 2026 in Review

IFP Advisors increased its Praxis Precision Medicines (PRAX) stake by 632% in Q3 2026, buying an estimated $52.3K and bringing the position to 183 shares worth $53.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2358.

IFP Advisors first reported a position in PRAX in Q3 2023 and has held it in 8 quarters since. 338 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • IFP Advisors held 183 shares of Praxis Precision Medicines worth $53.3K as of Q3 2026.
  • IFP Advisors bought 158 Praxis Precision Medicines shares in Q3 2026, an estimated $52.3K.
  • Praxis Precision Medicines made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #2358 holding.
  • IFP Advisors first reported a position in Praxis Precision Medicines in Q3 2023 and has held it in 8 quarters since.
  • 338 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.